Authors

Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events

The FDA approved oral semaglutide to reduce the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes (T2D).

Apixaban vs Rivaroxaban: A Clearer Choice for VTE?

Although evidence supports safety of apixaban and rivaroxaban relative to warfarin, researchers had not directly compared their bleeding risk until last year.

ADA 2026: The Diabetes Education Gap Clinicians Can't Afford to Ignore

Pharmacy Times speaks with Joyce Lee, PharmD, APh, FCCP, BCPS, BCACP, CDCES, to breakdown the diabetes education gap that clinicians can't afford to ignore.

Emerging Targeted Therapies in Breast Cancer: Expanding HER2-Low and TROP-2 Breakthroughs Require Pharmacist Knowledge and Vigilance

ADCs are reshaping metastatic breast cancer and pharmacists' roles in treatment management.

Administration of Tivozanib via Gastrostomy Tube: A Pharmacokinetic Analysis

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Opinion: The Pseudoscience of Personalized Compounding Prioritizes Convenience and Cost Over Science and Safety

Mass-produced compounded GLP-1 drugs bypass FDA safeguards, raising sterility, quality, and supply-chain risks—putting patients at risk despite ending shortages.

Managing Bispecifics at Scale: Capacity Planning, Financial Clearance, and Monitoring

Pharmacy streamlines bispecific programs with tailored operations, scheduling, order sets, and reimbursement checkpoints.

John Green: "Tuberculosis Anywhere Is a Threat to People Everywhere"

Tuberculosis is a long-standing global health issue that requires continued public health vigilance to prevent a resurgence of this preventable and curable disease.

Supporting Access to Precision Medicine in Community Care Settings

Precision medicine transforms cancer care, enhancing patient outcomes through targeted therapies, yet faces challenges in community access and biomarker testing.

Paradoxical Hypotension After Inadvertent Intravenous Administration of Epinephrine

Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.

An Overview of Vitamins and Supplements in Multiple Sclerosis

By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.

The Next Phase of Vertical Integration: Wholesalers Follow the PBM Playbook

Combating the Post-Pandemic Pharmacy Workforce Shortage

The pharmaceutical industry is facing a critical talent shortage caused by fewer students entering the field, burnout and a lack of stability. We offer ways to combat the shortage.

Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals

Thor Halfdanarson, MD, outlines real-world challenges in radiopharmaceutical production and delivery and highlights key questions for upcoming trials, including alpha vs beta emitters and long-term toxicity.

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.

Optimizing Self-Management for Outpatient Pharmacy Patients With Diabetes

The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.

Early Detection and Interconnected Risk: The Role of Albuminuria in Kidney and Cardiovascular Disease

Albuminuria (uACR) flags early vascular damage linking chronic kidney disease and cardiovascular risk.

A Novel Agent, Incretin Mimetics, and Potential Pharmacologicals for the Management of MASH

Optimizing Self-Management for Outpatient Pharmacy Patients With Diabetes

The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.

The Role of Physical Activity in Breast Cancer Risk Reduction and Survival

Pharmacists can educate patients on nonpharmacologic strategies that help improve survival outcomes.

Apixaban vs Rivaroxaban: A Clearer Choice for VTE?

Although evidence supports safety of apixaban and rivaroxaban relative to warfarin, researchers had not directly compared their bleeding risk until last year.

APhA 2025: Nakia Eldridge, PharmD, MBA, Highlights Must-See Sessions

Nakia Eldridge, PharmD, MBA, shares insights for health system and community pharmacists attending the 2025 APhA Annual Meeting & Exposition.

RSV Vaccination as a Public Health Priority: Protecting Communities Through Pharmacy Access

Updates in the Management of Transplant-Ineligible Patients With Multiple Myeloma

Explore the latest advancements in treating transplant-ineligible multiple myeloma, highlighting new therapies and clinical trial outcomes for improved patient care.

Designing for Safety: The Pharma Industry’s Role in Preventing Medication Errors

Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients.

Oncology PulsePoints: ASCO WBC Growth Factors Guidelines Update

Amber Clemmons PharmD, BCOP, FHOPA, highlights key changes in evidence grading, shared decision-making, and dosing strategies in neutropenia management.

Gut Microbiome and CAR T-Cell Therapy: Impact on Response, Toxicity, and Outcomes

Pharmacy Times interviews Robert R. Jeng, MD, on how the gut microbiome may influence CAR T-cell therapy response, toxicity, and persistence, as well as the challenges and future potential of microbiome-based interventions in improving patient outcomes.

Recognizing and Managing Skin Toxicities as Cancer Therapies Evolve

Expert highlights the critical need to manage skin toxicities in oncology, ensuring effective cancer treatments while addressing patient well-being and adherence.